Department of Medicine

Stop the Start: Therapeutics Targeting C5aR1 to Treat Early Rheumatoid Arthritis as a New Pathway to Precision Medicine

Written by Department of Medicine | October 11, 2022

Watch the Department of Medicine's Oct. 11, 2022 Research & Innovation Conference – "Stop the Start: Therapeutics Targeting C5aR1 to Treat Early Rheumatoid Arthritis as a New Pathway to Precision Medicine" with Nirmal K. Banda, PhD, MPhil, MS, research professor in the Division of Rheumatology.